房颤抗凝-话题@MedSci

#房颤抗凝#

25篇内容 | 815人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1694827, encodeId=86ff169482e71, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=AJKD：血液透析患者新发房颤抗凝药物的使用及阿哌沙班的给药适宜性, objectType=article, longId=218317, objectId=6df321831e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6df321831e4d, replyNumber=0, likeNumber=31, createdTime=2022-02-15, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6df321831e4d, moduleTitle=AJKD：血液透析患者新发房颤抗凝药物的使用及阿哌沙班的给药适宜性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6df321831e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694825, encodeId=7d02169482510, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=华法林、达比加群、利伐沙班怎么用？5张图掌握房颤抗凝！, objectType=article, longId=216535, objectId=54ca216535e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54ca216535e9, replyNumber=0, likeNumber=40, createdTime=2022-06-12, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54ca216535e9, moduleTitle=华法林、达比加群、利伐沙班怎么用？5张图掌握房颤抗凝！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54ca216535e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694826, encodeId=63231694826f6, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=ESC 2021丨陈纪言、董吁钢、罗建方、董少红、刘启明：聚焦艾多沙班全新RCT和RWE结果，紧跟房颤抗凝前沿, objectType=article, longId=217426, objectId=f71a21e42610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f71a21e42610, replyNumber=0, likeNumber=33, createdTime=2022-01-05, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f71a21e42610, moduleTitle=ESC 2021丨陈纪言、董吁钢、罗建方、董少红、刘启明：聚焦艾多沙班全新RCT和RWE结果，紧跟房颤抗凝前沿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f71a21e42610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694824, encodeId=c0ea169482492, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=房颤抗凝后出血，那出血后，什么时候再次继续抗凝, objectType=article, longId=212427, objectId=b15a21242e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b15a21242e21, replyNumber=0, likeNumber=32, createdTime=2021-08-28, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b15a21242e21, moduleTitle=房颤抗凝后出血，那出血后，什么时候再次继续抗凝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b15a21242e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694822, encodeId=8d481694822d4, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=房颤抗凝后为何还会发生中风？日本研究, objectType=article, longId=199715, objectId=3436199e15ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3436199e15ef, replyNumber=0, likeNumber=41, createdTime=2020-09-06, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3436199e15ef, moduleTitle=房颤抗凝后为何还会发生中风？日本研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3436199e15ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694823, encodeId=07e81694823fb, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=Stroke : 脑中风后，房颤抗凝治疗的患者，小血管疾病会增加中风复发风险, objectType=article, longId=205395, objectId=857420539504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=857420539504, replyNumber=0, likeNumber=49, createdTime=2021-05-28, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=857420539504, moduleTitle=Stroke : 脑中风后，房颤抗凝治疗的患者，小血管疾病会增加中风复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=857420539504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694821, encodeId=97251694821fa, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=房颤抗凝“药”知道, objectType=article, longId=177518, objectId=ed081e7518a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed081e7518a3, replyNumber=0, likeNumber=31, createdTime=2019-09-02, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed081e7518a3, moduleTitle=房颤抗凝“药”知道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed081e7518a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694820, encodeId=f3221694820fc, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=CSA&TISC2019丨方堃教授畅谈房颤抗凝治疗的新突破与进展, objectType=article, longId=174577, objectId=47a41e4577d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47a41e4577d4, replyNumber=0, likeNumber=42, createdTime=2019-12-06, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47a41e4577d4, moduleTitle=CSA&TISC2019丨方堃教授畅谈房颤抗凝治疗的新突破与进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47a41e4577d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694819, encodeId=37221694819a4, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=JACC Clin Electrophysiol：多种疾病继发的房颤抗凝治疗及缺血性脑卒中和出血的风险, objectType=article, longId=146422, objectId=d0e31464223f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0e31464223f, replyNumber=0, likeNumber=41, createdTime=2018-12-28, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0e31464223f, moduleTitle=JACC Clin Electrophysiol：多种疾病继发的房颤抗凝治疗及缺血性脑卒中和出血的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0e31464223f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694818, encodeId=cb14169481853, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=Biosens Bioelectron：苏州医工所在房颤抗凝快速检测方面取得进展, objectType=article, longId=124852, objectId=896a12485231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896a12485231, replyNumber=0, likeNumber=30, createdTime=2018-04-25, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896a12485231, moduleTitle=Biosens Bioelectron：苏州医工所在房颤抗凝快速检测方面取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896a12485231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694816, encodeId=a3c416948162c, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=房颤抗凝治疗的3.0时代, objectType=article, longId=104254, objectId=780010425441, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780010425441, replyNumber=0, likeNumber=24, createdTime=2017-10-24, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780010425441, moduleTitle=房颤抗凝治疗的3.0时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=780010425441)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694817, encodeId=f91f169481e23, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=Stroke：房颤抗凝有没有年龄限制？, objectType=article, longId=106132, objectId=c24a10613243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c24a10613243, replyNumber=0, likeNumber=38, createdTime=2017-10-08, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c24a10613243, moduleTitle=Stroke：房颤抗凝有没有年龄限制？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c24a10613243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694815, encodeId=f61c1694815a1, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=房颤抗凝——坚守传统还是勇往直前, objectType=article, longId=93132, objectId=608393132fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=608393132fa, replyNumber=0, likeNumber=35, createdTime=2017-10-06, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=608393132fa, moduleTitle=房颤抗凝——坚守传统还是勇往直前, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=608393132fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694814, encodeId=f541169481482, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=栓塞或出血：老年房颤抗凝的矛盾与抉择, objectType=article, longId=92628, objectId=42949262890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42949262890, replyNumber=0, likeNumber=49, createdTime=2017-09-06, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42949262890, moduleTitle=栓塞或出血：老年房颤抗凝的矛盾与抉择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42949262890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694812, encodeId=f609169481288, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=【2015长城会】老年房颤抗凝：栓塞或出血的矛盾如何解决？, objectType=article, longId=58269, objectId=f79458269a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f79458269a5, replyNumber=0, likeNumber=25, createdTime=2016-03-04, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f79458269a5, moduleTitle=【2015长城会】老年房颤抗凝：栓塞或出血的矛盾如何解决？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f79458269a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694813, encodeId=8d631694813f6, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=Lancet：新型生物标志物ABC—房颤抗凝出血风险评分系统效果较好, objectType=article, longId=66052, objectId=a75b6605243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a75b6605243, replyNumber=0, likeNumber=35, createdTime=2016-08-23, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a75b6605243, moduleTitle=Lancet：新型生物标志物ABC—房颤抗凝出血风险评分系统效果较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a75b6605243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694809, encodeId=e5aa16948093d, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=全球房颤抗凝治疗现状：GARFIELD-AF研究结果公布及分析, objectType=article, longId=55691, objectId=543c5569161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=543c5569161, replyNumber=0, likeNumber=40, createdTime=2016-01-29, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=543c5569161, moduleTitle=全球房颤抗凝治疗现状：GARFIELD-AF研究结果公布及分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=543c5569161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694811, encodeId=7028169481123, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=【2015长城会】张萍教授：从指南看房颤抗凝策略的变迁, objectType=article, longId=58186, objectId=5e4158186f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e4158186f7, replyNumber=0, likeNumber=0, createdTime=2016-01-27, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e4158186f7, moduleTitle=【2015长城会】张萍教授：从指南看房颤抗凝策略的变迁, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e4158186f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694810, encodeId=f6451694810b9, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=【2015长城会】张萍教授谈房颤抗凝治疗新进展, objectType=article, longId=58180, objectId=34185818045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34185818045, replyNumber=0, likeNumber=26, createdTime=2016-04-18, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34185818045, moduleTitle=【2015长城会】张萍教授谈房颤抗凝治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34185818045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694808, encodeId=7f781694808e0, content=<a href='/topic/show?id=a7385426313' target=_blank style='color:#2F92EE;'>#房颤抗凝#</a>, objectTitle=马长生：房颤抗凝治疗适应证新认识, objectType=article, longId=55010, objectId=0d3355010c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d3355010c0, replyNumber=0, likeNumber=39, createdTime=2016-02-14, rootId=0, userName=xiongke020, userId=8df129768056, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d3355010c0, moduleTitle=马长生：房颤抗凝治疗适应证新认识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d3355010c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

房颤抗凝

2020-05-29

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

AJKD：血液透析患者新发房颤抗凝药物的使用及阿哌沙班的给药适宜性

2022-02-15

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

华法林、达比加群、利伐沙班怎么用？5张图掌握房颤抗凝！

2022-06-12

一叶知秋 (审核中...)

前往app查看评论内容

#房颤抗凝#

ESC 2021丨陈纪言、董吁钢、罗建方、董少红、刘启明：聚焦艾多沙班全新RCT和RWE结果，紧跟房颤抗凝前沿

2022-01-05

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

房颤抗凝后出血，那出血后，什么时候再次继续抗凝

2021-08-28

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

房颤抗凝后为何还会发生中风？日本研究

2020-09-06

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

Stroke : 脑中风后，房颤抗凝治疗的患者，小血管疾病会增加中风复发风险

2021-05-28

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

房颤抗凝“药”知道

2019-09-02

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

CSA&TISC2019丨方堃教授畅谈房颤抗凝治疗的新突破与进展

2019-12-06

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

JACC Clin Electrophysiol：多种疾病继发的房颤抗凝治疗及缺血性脑卒中和出血的风险

2018-12-28

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

Biosens Bioelectron：苏州医工所在房颤抗凝快速检测方面取得进展

2018-04-25

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

房颤抗凝治疗的3.0时代

2017-10-24

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

Stroke：房颤抗凝有没有年龄限制？

2017-10-08

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

房颤抗凝——坚守传统还是勇往直前

2017-10-06

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

栓塞或出血：老年房颤抗凝的矛盾与抉择

2017-09-06

仁心济世 (审核中...)

前往app查看评论内容

#房颤抗凝#

【2015长城会】老年房颤抗凝：栓塞或出血的矛盾如何解决？

2016-03-04

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

Lancet：新型生物标志物ABC—房颤抗凝出血风险评分系统效果较好

2016-08-23

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

全球房颤抗凝治疗现状：GARFIELD-AF研究结果公布及分析

2016-01-29

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

【2015长城会】张萍教授：从指南看房颤抗凝策略的变迁

2016-01-27

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

【2015长城会】张萍教授谈房颤抗凝治疗新进展

2016-04-18

xiongke020 (审核中...)

前往app查看评论内容

#房颤抗凝#

马长生：房颤抗凝治疗适应证新认识

2016-02-14

科室
- - 订阅+
  - 更多科室
工具
服务